10 Best-Selling Brand-Name Drugs in 2015

AUGUST 17, 2015
Allison Gilchrist, Associate Editor
2. Abilify (Otsuka) - $7.2 billion

This antipsychotic drug demonstrated superior effectiveness over rival schizophrenia treatment Invega Sustenna in a head-to head study.
In the first half of 2015, 8.3 million total prescriptions were written for Abilify.
The FDA approved the first generic versions of Abilify to treat schizophrenia and bipolar disorder in April 2015.